Sai Parenteral's

  • Market Cap: Small Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: INE0H9F01037
  • NSEID: SAIPARENT
  • BSEID: 544742
INR
565.50
14.3 (2.59%)
BSENSE

Jun 11, 11:01 AM

BSE+NSE Vol: 2.22 lacs

  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-summaryPrice Point
High/Low

1Day

52 Week

Valuation
Technical
Day's Volume

CASH

2.22 lacs (5.93%) Volume

Shareholding (Apr 2026)

FII

5.73%

Held by 9 FIIs

DII

12.86%

Held by 6 DIIs

Promoter

51.16%

Why is Sai Parenterals Ltd falling/rising?

11-Jun-2026

As of 10-Jun, the stock price of Sai Parenterals Ltd is Rs 551.20, down 1.73% after two days of gains. Despite being near its 52-week high, recent performance and a significant drop in trading volume suggest a bearish trend.

As of 10-Jun, the stock price of Sai Parenterals Ltd is currently at Rs 551.20, reflecting a decrease of Rs 9.7 or 1.73%. This decline comes after a trend reversal, as the stock has fallen following two consecutive days of gains. Additionally, the stock has underperformed its sector by 0.57% today.<BR><BR>The stock touched an intraday low of Rs 546.9, which is a decrease of 2.5% from its previous price. Furthermore, there has been a significant drop in investor participation, with delivery volume on June 9 falling by 61.25% compared to the 5-day average. Despite trading above its moving averages for 5, 20, 50, 100, and 200 days, the overall sentiment appears to be negative, contributing to the stock's current decline. <BR><BR>While the stock is still close to its 52-week high, being only 3.05% away from Rs 572.1, the recent performance and reduced trading volume indicate a bearish trend in the short term.

View full answer

What does Sai Parenteral's do?

11-Jun-2026

Sai Parenterals Ltd is a small-cap company in the Pharmaceuticals & Biotechnology industry, specializing in parenteral products. As of March 2026, it reported net sales of ₹57 Cr and a net profit of ₹10 Cr, with a market cap of ₹2,479 Cr.

Overview: <BR>Sai Parenterals Ltd operates in the Pharmaceuticals & Biotechnology industry and is categorized as a Small Cap company.<BR><BR>History: <BR>Sai Parenterals Ltd was originally incorporated as 'Sai Parenteral's Private Limited' in 2001. The company transitioned to a Public Limited Company and changed its name to 'Sai Parenteral's Limited' on January 17, 2022. The most recent quarterly results reported net sales and net profit for the period ending March 2026.<BR><BR>Financial Snapshot: <BR>Net Sales: 57 Cr (Quarterly Results - Mar 2026) <BR>Net Profit: 10 Cr (Quarterly Results - Mar 2026) <BR>Market Cap: INR 2,479 Cr (Small Cap)<BR><BR>Key Metrics: <BR>P/E: 172.00 <BR>Industry P/E: 34 <BR>Dividend Yield: 0.00% <BR>Debt-Equity: -0.17 <BR>Return on Equity: 2.91% <BR>Price to Book: 5.04<BR><BR>Contact Details: <BR>No Company Details Available <BR>Registrar Address: Not available.

View full answer

Which are the latest news on Sai Parenteral's?

10-Jun-2026

When is the next results date for Sai Parenterals Ltd?

20-May-2026

Sai Parenterals Ltd will announce its results on 23 May 2026.

Sai Parenterals Ltd is scheduled to declare its results on 23 May 2026.

View full answer
iScoreScore
Click here to find our call on this stock
Strong Sell
Sell
Hold
Buy
Strong Buy

Dashboard

Icon
Unrated Stock - No Analysis Available
stock-summaryMojo Parameters

Mojo Parameters

Loading Valuation Snapshot...

Stock DNA

stock-summary
Industry

Pharmaceuticals & Biotechnology

stock-summary
Market cap

INR 2,498 Cr (Small Cap)

stock-summary
P/E

172.00

stock-summary
Industry P/E

NA

stock-summary
Dividend Yield

0.00%

stock-summary
Debt Equity

-0.17

stock-summary
Return on Equity

2.91%

stock-summary
Price to Book

5.00

Revenue and Profits:
Net Sales:
57 Cr
(Quarterly Results - Mar 2026)
Net Profit:
10 Cr
stock-summaryTotal Returns
Total Returns (Price + Dividend) stock-summary
Icon
Company does not have enough history
Risk Adjusted Returns v/s stock-summary
Returns Beta
Icon
Beta has not been calculated since enough price history is not available
stock-summaryNews & Corporate Actions

Announcements stock-summary

Announcement under Regulation 30 (LODR)-Earnings Call Transcript

29-May-2026 | Source : BSE

Earnings Call Transcript

Announcement under Regulation 30 (LODR)-Award_of_Order_Receipt_of_Order

28-May-2026 | Source : BSE

Receipt of Order

Announcement under Regulation 30 (LODR)-Investor Presentation

26-May-2026 | Source : BSE

Investor Presentation

Corporate Actions stock-summary

stock-summary
BOARD MEETING

No Upcoming Board Meetings

stock-summary
DIVIDEND

No Dividend history available

stock-summary
SPLITS

No Splits history available

stock-summary
BONUS

No Bonus history available

stock-summary
RIGHTS

No Rights history available

stock-summaryKey Factors

Quality key factors stock-summary

Factor
Value
Sales Growth (5y)
0
EBIT Growth (5y)
0
EBIT to Interest (avg)
1.90
Debt to EBITDA (avg)
8.61
Net Debt to Equity (avg)
0
Sales to Capital Employed (avg)
0.46
Tax Ratio
Tax Ratio is Negative%
Dividend Payout Ratio
0
Pledged Shares
0
Institutional Holding
18.59%
ROCE (avg)
5.37%
ROE (avg)
0

Valuation key factors

Factor
Value
P/E Ratio
172
Industry P/E
0
Price to Book Value
5.00
EV to EBIT
108.42
EV to EBITDA
61.21
EV to Capital Employed
5.82
EV to Sales
6.22
PEG Ratio
NA
Dividend Yield
NA
ROCE (Latest)
5.37%
ROE (Latest)
2.91%

Technicals key factors

Indicator
Weekly
Monthly
MACD
RSI
Bollinger Bands
KST
Dow Theory
Bullish
OBV
No Trend
stock-summary Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish  Turned 
stock-summaryShareholding
Shareholding Snapshot : Apr 2026stock-summary
Shareholding Compare (%holding) stock-summary
Majority shareholders

Promoters

Pledged Promoter Holdings

None

Mutual Funds

Held by 1 Schemes (3.81%)

FIIs

Held by 9 FIIs (5.73%)

Promoter with highest holding

Vijitha Gorrepati (0.29%)

Highest Public shareholder

Quant Mutual Fund - Quant Small Cap Fund (0.038%)

Individual Investors Holdings

22.67%

stock-summaryFinancial
[
  {
    "link": "quarterly",
    "btn_text": "All Quarterly Results",
    "header": "Quarterly Results Snapshot (Standalone) - Mar'26 - QoQ",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "Not Applicable: The company has declared_date for only one period",
        "dir": 0
      },
      {
        "prefix": "Standalone Net Profit ",
        "suffix": "Not Applicable: The company has declared_date for only one period",
        "dir": 0
      }
    ],
    "table": {
      "header": [
        "Mar'26",
        "Dec'25",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "56.79",
          "val2": "38.48",
          "chgp": "47.58%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "13.22",
          "val2": "3.98",
          "chgp": "232.16%",
          "chgp_class": "positive"
        },
        {
          "field": "Interest",
          "val1": "3.42",
          "val2": "2.12",
          "chgp": "61.32%",
          "chgp_class": "negative"
        },
        {
          "field": "Exceptional Items",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Standalone Net Profit",
          "val1": "9.95",
          "val2": "0.36",
          "chgp": "2,663.89%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "23.28%",
          "val2": "10.34%",
          "chgp": "12.94%",
          "chgp_class": "positive"
        }
      ]
    }
  },
  {
    "link": "half-yearly",
    "btn_text": "All Half Yearly Results",
    "alert": "No Half Yearly Results declared by Sai Parenteral's"
  },
  {
    "link": "nine-monthly",
    "btn_text": "All Nine Monthly Results",
    "alert": "No Nine Monthly Results declared by Sai Parenteral's"
  },
  {
    "link": "annual",
    "btn_text": "All Annual Results",
    "header": "Annual Results Snapshot (Standalone) - Mar'26",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in year ended Mar 2026 is 30.56% vs 9.11% in Mar 2025",
        "dir": 1
      },
      {
        "prefix": "Standalone Net Profit ",
        "suffix": "YoY Growth in year ended Mar 2026 is 62.28% vs 44.41% in Mar 2025",
        "dir": 1
      }
    ],
    "table": {
      "header": [
        "Mar'26",
        "Mar'25",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "162.25",
          "val2": "124.27",
          "chgp": "30.56%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "30.58",
          "val2": "26.95",
          "chgp": "13.47%",
          "chgp_class": "positive"
        },
        {
          "field": "Interest",
          "val1": "8.77",
          "val2": "7.31",
          "chgp": "19.97%",
          "chgp_class": "negative"
        },
        {
          "field": "Exceptional Items",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Standalone Net Profit",
          "val1": "16.78",
          "val2": "10.34",
          "chgp": "62.28%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "18.85%",
          "val2": "21.69%",
          "chgp": "-2.84%",
          "chgp_class": "negative"
        }
      ]
    }
  }
]

Quarterly Results Snapshot (Standalone) - Mar'26 - QoQstock-summary

Mar'26
Dec'25
Change(%)
Net Sales
56.79
38.48
47.58%
Operating Profit (PBDIT) excl Other Income
13.22
3.98
232.16%
Interest
3.42
2.12
61.32%
Exceptional Items
0.00
0.00
Standalone Net Profit
9.95
0.36
2,663.89%
Operating Profit Margin (Excl OI)
23.28%
10.34%
12.94%
Values in Rs Cr.
Net Sales

Not Applicable: The company has declared_date for only one period

Standalone Net Profit

Not Applicable: The company has declared_date for only one period

Annual Results Snapshot (Standalone) - Mar'26stock-summary

Mar'26
Mar'25
Change(%)
Net Sales
162.25
124.27
30.56%
Operating Profit (PBDIT) excl Other Income
30.58
26.95
13.47%
Interest
8.77
7.31
19.97%
Exceptional Items
0.00
0.00
Standalone Net Profit
16.78
10.34
62.28%
Operating Profit Margin (Excl OI)
18.85%
21.69%
-2.84%
Values in Rs Cr.
Direction Arrows
Net Sales

YoY Growth in year ended Mar 2026 is 30.56% vs 9.11% in Mar 2025

Direction Arrows
Standalone Net Profit

YoY Growth in year ended Mar 2026 is 62.28% vs 44.41% in Mar 2025

stock-summaryCompany CV
About Sai Parenterals Ltd stock-summary
stock-summary
Sai Parenterals Ltd
Small Cap
Pharmaceuticals & Biotechnology
Sai Parenteral's Limited was originally incorporated as `Sai Parenteral's Private Limited', a Private Limited Company on January 12, 2001, with the Registrar of Companies, at Hyderabad. Thereafter, Company was converted into a Public Limited Company and the name of Company was changed to `Sai Parenteral's Limited' w.e.f January 17, 2022.
Company Coordinates stock-summary
Icon
No Company Details Available